Lipid metabolic reprogramming in Cancer radiation resistance: Mechanisms and therapeutic implications.

Authors

Hanxia Zhang, Hui Liu, Ming Jin, Kaitai Liu

Published in

Biochimica et biophysica acta. Reviews on cancer. Pages 189731. Oct 08, 2026. Epub Oct 08, 2026.

Abstract

Currently, cancer treatment mainly includes surgery, radiotherapy, chemotherapy, immunotherapy, and targeted therapy, wherein radiotherapy is one of the core modalities. However, its efficacy is often limited by radiotherapy resistance in the tumour cells. In recent years, studies have found that tumour cells undergo lipid metabolic reprogramming to enhance lipid synthesis, uptake, and storage, thereby adapting to the energy and structural adjustment demands imposed by radiotherapy, gaining survival advantage and developing radiation resistance. This review mainly focused on the role of lipid metabolic changes, including fatty acids, cholesterol, and phospholipids, in radiation resistance, aiming to provide ideas for achieving individualised precision radiotherapy.

PMID:
42849800
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.